SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------
FORM 8-K
Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
March 12, 2004
AMERICAN CONSOLIDATED MANAGEMENT GROUP, INC.
-----------------------------------------------------
(Exact name of registrant as specified in its charter)
Utah
----------------------------------------------
(State or other jurisdiction of incorporation)
0-20642 87-0375093
------------------------ ---------------------------------
(Commission file number) (IRS employer identification no.)
714 Fairview Road, Greer, SC 29651
------------------------------------------------ ----------
(Address of principal executive offices) (Zip code)
(864) 848-1900
---------------------------------------------------
(Registrant's telephone number, including area code)
This document contains a total of 3 pages.
Item 5. Other Events
On March 18, 2004, the Company released the following:
AMERICAN CONSOLIDATED MANAGEMENT GROUP, INC.
714 Fairview Road
Greer, South Carolina 29651
March 18, 2004
On March 12, 2004, the Board of Directors of American Consolidated
Management Group, Inc. ("ACMI"), by unanimous written consent resolved to
negotiate and enter into a technology transfer/license agreement with Dr. Jack
Watkins of San Diego, California, whereby ACMI would acquire an exclusive
license to enhance, commercialize, manufacturer and market the all-natural
plant product compound developed by Dr. Watkins in the United States, Mexico,
Central American, Canada and all other countries in the European Union.
On March 17, 2004, ACMI entered into a preliminary technology
transfer/license agreement with Dr. Jack Watkins, the inventor/developer of the
licensed product. The technology transfer/license agreement provides ACMI with
the exclusive license to enhance, commercialize, manufacture and market the
all-natural plant product in the United States, Mexico, Central America,
Canada, and all countries in the European Union.
This technology is an all-natural product composed of various fruits
and vegetables that allows the vitamins, minerals and phytonutrients in those
fruits and vegetables to be added to processed food products, enhancing their
nutritional value to the consumer.
Dr. Jack Watkins' scientific breakthrough, in simple terms, minimizes
the degradation of the natural vitamins, minerals and phytonutrients of fruits
and vegetables while being further processed in most processed food
applications. The inclusion of this technology in processed food greatly
enhances the nutritional value of those food products so they deliver the
equivalent vitamin, mineral and phytonutrient value of 3-5 servings of fruits
and vegetables in one serving of the respective food product.
The study and application of Phytonutrients is now considered the "Next
Frontier in Nutrition". ACMI's all-natural product will allow food
manufacturers to increase the nutrient value of their food products as the
knowledge of phytonutrients continues to expand. The commercialization of this
new technology will serve as the platform from which ACMI will develop. This
new technology is the primary focus of ACMI's growth in the Functional Foods
segment of the food Industry.
ACMI is a newly-reorganized publicly traded company (Bulletin Board/Pink
Sheets) involved in the development and commercialization of natural plant
products for use by established food manufacturers in their products, aimed at
the fast growing Functional Foods segment of the $900 billion dollar United
States domestic food industry.
Portions of this document may constitute "forward-looking statements"
as defined by federal securities law. Although the company believes any such
statements are based upon reasonable assumptions, there is no assurance that
actual outcomes will not be materially different. Any such statements are made
in reliance upon the "safe harbor" protections provided under the Private
Securities Reform Act of 1995. Additional information about the company and
issues which could lead to material changes in performance are contained in the
company's annual reports and other materials filed with the Securities and
Exchange Commission.
For information on American Consolidated Management Group, Inc., please
contact: Tammy Giles at (864) 848-1900.
This news release contains forward-looking statements within the meaning
of the Securities Act of 1933 and the Securities Exchange Act of 1934, as
amended. Such statements are subject to risks and uncertainties that could
cause actual results to vary materially from those projected in the forward-
looking statements. The Company may experience significant fluctuations in
future operating results due to a number of economic conditions, risks in
product development, the effect of the Company's accounting policies and other
risk factors detailed in the Company's SEC filings. These factors and others
could cause operating results to vary significantly from those in prior periods
and those projected in forward-looking statements. Additional information with
respect to these and other factors, which could materially affect the Company
and its operations, are included on certain forms the Company files with the
Securities and Exchange Commission. Although the Company believes any such
statements are based upon reasonable assumptions, there is no assurance that
the actual outcomes will not be materially different. Any such statements are
made in reliance upon the "safe harbor" protections provided under the Private
Securities Reform Act of 1995.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AMERICAN CONSOLIDATED MANAGEMENT GROUP, INC.
By /s/ George E. Mappin
-----------------------------
Date: March 18, 2004 George E. Mappin
Secretary, Acting Treasurer and Controller,
and Director